{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:32:48Z","timestamp":1791279168479,"version":"4.1.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Percutaneous peptide immunization (PPI) is a simple and noninvasive immunization approach to induce potent CTL responses by peptide delivery via skin with the stratum corneum removed. After such a barrier disruption in human skin, epidermal Langerhans cells, although functionally matured through the up-regulation of HLA expression and costimulatory molecules, were found to emigrate with a reduced number of dendrites. CD8+ populations binding to MHC-peptide tetramers\/pentamers and producing IFN-\u03b3 appeared in the blood after PPI with HLA class I\u2013restricted antigenic peptides. PPI with melanoma-associated peptides reduced the lesion size and suppressed further development of tumors in four of seven patients with advanced melanoma. These beneficial effects were accompanied by the generation of circulating CTLs with in vitro cytolytic activity and extensive infiltration of tetramer\/pentamer-binding cells into regressing lesions. PPI elicited neither local nor systemic toxicity or autoimmunity, except for vitiligo, in patients with melanoma. Therefore, PPI represents a novel therapeutic intervention for cancer in the clinical setting. (Cancer Res 2006; 66(20): 10136-44)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-1029","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T09:42:10Z","timestamp":1161164530000},"page":"10136-10144","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Induction of Therapeutically Relevant Cytotoxic T Lymphocytes in Humans by Percutaneous Peptide Immunization"],"prefix":"10.1158","volume":"66","author":[{"given":"Hiroaki","family":"Yagi","sequence":"first","affiliation":[{"name":"1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Hashizume","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Horibe","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Yoshinari","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Hata","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ohshima","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Ito","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takigawa","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Shibaki","sequence":"additional","affiliation":[{"name":"2Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"2Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Seo","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,10,17]]},"reference":[{"key":"2022061622275233600_B1","doi-asserted-by":"crossref","unstructured":"Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med\u20081996; 2: 52\u20138.","DOI":"10.1038\/nm0196-52"},{"key":"2022061622275233600_B2","doi-asserted-by":"crossref","unstructured":"Kundu SK, Dupuis M, Sette A, et al. Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization. AIDS Res Hum Retroviruses\u20081998; 14: 1669\u201378.","DOI":"10.1089\/aid.1998.14.1669"},{"key":"2022061622275233600_B3","doi-asserted-by":"crossref","unstructured":"Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med\u20081998; 4: 328\u201332.","DOI":"10.1038\/nm0398-328"},{"key":"2022061622275233600_B4","doi-asserted-by":"crossref","unstructured":"Dhodapkar MV, Steinman RM. Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans. Blood\u20082002; 100: 174\u20137.","DOI":"10.1182\/blood.V100.1.174"},{"key":"2022061622275233600_B5","doi-asserted-by":"crossref","unstructured":"Dhodapkar MV, Krasovsky J, Steinman RM, Bhardwaj N. Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes. J Clin Invest\u20082000; 105: R9\u201314.","DOI":"10.1172\/JCI9051"},{"key":"2022061622275233600_B6","doi-asserted-by":"crossref","unstructured":"Paczesny S, Banchereau J, Wittkowski KM, Saracino G, Fay J, Palucka AK. Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells. J Exp Med\u20082004; 199: 1503\u201311.","DOI":"10.1084\/jem.20032118"},{"key":"2022061622275233600_B7","doi-asserted-by":"crossref","unstructured":"Schuler-Thurner B, Schultz ES, Berger TG, et al. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med\u20082002; 195: 1279\u201388.","DOI":"10.1084\/jem.20012100"},{"key":"2022061622275233600_B8","doi-asserted-by":"crossref","unstructured":"Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G. Dendritic cells as vectors for therapy. Cell\u20082001; 106: 271\u20134.","DOI":"10.1016\/S0092-8674(01)00448-2"},{"key":"2022061622275233600_B9","doi-asserted-by":"crossref","unstructured":"Jonuleit H, Giesecke-Tuettenberg A, Tuting T, et al. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer\u20082001; 93: 243\u201351.","DOI":"10.1002\/ijc.1323"},{"key":"2022061622275233600_B10","unstructured":"de Vries IJ, Krooshoop DJ, Scharenborg NM, et al. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res\u20082003; 63: 12\u20137."},{"key":"2022061622275233600_B11","unstructured":"de Vries IJ, Lesterhuis WJ, Scharenborg NM, et al. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin Cancer Res\u20082003; 9: 5091\u2013100."},{"key":"2022061622275233600_B12","doi-asserted-by":"crossref","unstructured":"Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med\u20082004; 10: 475\u201380.","DOI":"10.1038\/nm1039"},{"key":"2022061622275233600_B13","doi-asserted-by":"crossref","unstructured":"Engleman EG. Dendritic cell-based cancer immunotherapy. Semin Oncol\u20082003; 30: 23\u20139.","DOI":"10.1016\/S0093-7754(03)00229-X"},{"key":"2022061622275233600_B14","unstructured":"Jakob T, Udey MC. Epidermal Langerhans cells: from neurons to nature's adjuvants. Adv Dermatol\u20081999; 14: 209\u201358."},{"key":"2022061622275233600_B15","doi-asserted-by":"crossref","unstructured":"Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol\u20082000; 18: 767\u2013811.","DOI":"10.1146\/annurev.immunol.18.1.767"},{"key":"2022061622275233600_B16","doi-asserted-by":"crossref","unstructured":"Raz E, Carson DA, Parker SE, et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A\u20081994; 91: 9519\u201323.","DOI":"10.1073\/pnas.91.20.9519"},{"key":"2022061622275233600_B17","doi-asserted-by":"crossref","unstructured":"Bouloc A, Walker P, Grivel JC, Vogel JC, Katz SI. Immunization through dermal delivery of protein-encoding DNA: a role for migratory dendritic cells. Eur J Immunol\u20081999; 29: 446\u201354.","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<446::AID-IMMU446>3.0.CO;2-A"},{"key":"2022061622275233600_B18","doi-asserted-by":"crossref","unstructured":"Granstein RD, Ding W, Ozawa H. Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA. J Invest Dermatol\u20082000; 114: 632\u20136.","DOI":"10.1046\/j.1523-1747.2000.00929.x"},{"key":"2022061622275233600_B19","doi-asserted-by":"crossref","unstructured":"Belyakov IM, Hammond SA, Ahlers JD, Glenn GM, Berzofsky JA. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J Clin Invest\u20082004; 113: 998\u20131007.","DOI":"10.1172\/JCI20261"},{"key":"2022061622275233600_B20","doi-asserted-by":"crossref","unstructured":"Seo N, Tokura Y, Nishijima T, Hashizume H, Furukawa F, Takigawa M. Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc Natl Acad Sci U S A\u20082000; 97: 371\u20136.","DOI":"10.1073\/pnas.97.1.371"},{"key":"2022061622275233600_B21","doi-asserted-by":"crossref","unstructured":"Nishijima T, Tokura Y, Imokawa G, Seo N, Furukawa F, Takigawa M. Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption. J Invest Dermatol\u20081997; 109: 175\u201382.","DOI":"10.1111\/1523-1747.ep12319282"},{"key":"2022061622275233600_B22","doi-asserted-by":"crossref","unstructured":"Godefroy S, Peyre M, Garcia N, Muller S, Sesardic D, Partidos CD. Effect of skin barrier disruption on immune responses to topically applied cross-reacting material, CRM197, of diphtheria toxin. Infect Immun\u20082005; 73: 4803\u20139.","DOI":"10.1128\/IAI.73.8.4803-4809.2005"},{"key":"2022061622275233600_B23","doi-asserted-by":"crossref","unstructured":"Nagatani T, Ichiyama S, Onuma R, et al. The use of DAV (DTIC, ACNU and VCR) and natural interferon-\u03b2 combination therapy in malignant melanoma. Acta Derm Venereol\u20081995; 75: 494.","DOI":"10.2340\/0001555575494"},{"key":"2022061622275233600_B24","doi-asserted-by":"crossref","unstructured":"Sliz P, Michielin O, Cerottini JC, et al. Crystal structures of two closely related but antigenically distinct HLA-A2\/melanocyte-melanoma tumor-antigen peptide complexes. J Immunol\u20082001; 167: 3276\u201384.","DOI":"10.4049\/jimmunol.167.6.3276"},{"key":"2022061622275233600_B25","doi-asserted-by":"crossref","unstructured":"Yagi H, Tokura Y, Furukawa F, Takigawa M. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-\u03b3. J Invest Dermatol\u20081996; 107: 827\u201332.","DOI":"10.1111\/1523-1747.ep12330845"},{"key":"2022061622275233600_B26","doi-asserted-by":"crossref","unstructured":"Cooper KD, Fox P, Neises G, Katz SI. Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: initial depression of Langerhans cell-dependent function is followed by the appearance of T6\u2212 Dr+ cells that enhance epidermal alloantigen presentation. J Immunol\u20081985; 134: 129\u201337.","DOI":"10.4049\/jimmunol.134.1.129"},{"key":"2022061622275233600_B27","doi-asserted-by":"crossref","unstructured":"Yu RC, Abrams DC, Alaibac M, Chu AC. Morphological and quantitative analyses of normal epidermal Langerhans cells using confocal scanning laser microscopy. Br J Dermatol\u20081994; 131: 843\u20138.","DOI":"10.1111\/j.1365-2133.1994.tb08587.x"},{"key":"2022061622275233600_B28","doi-asserted-by":"crossref","unstructured":"Yagi H, Tokura Y, Wakita H, Furukawa F, Takigawa M. TCRV\u03b27+ Th2 cells mediate UVB-induced suppression of murine contact photosensitivity by releasing IL-10. J Immunol\u20081996; 156: 1824\u201331.","DOI":"10.1016\/0923-1811(95)93943-U"},{"key":"2022061622275233600_B29","doi-asserted-by":"crossref","unstructured":"Hashizume H, Takigawa M, Tokura Y. Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol\u20082002; 168: 5359\u201368.","DOI":"10.4049\/jimmunol.168.10.5359"},{"key":"2022061622275233600_B30","doi-asserted-by":"crossref","unstructured":"Kuzushima K, Hayashi N, Kimura H, Tsurumi T. Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8+ T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood\u20082001; 98: 1872\u201381.","DOI":"10.1182\/blood.V98.6.1872"},{"key":"2022061622275233600_B31","doi-asserted-by":"crossref","unstructured":"Seo N, Hayakawa S, Takigawa M, Tokura Y. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity. Immunology\u20082001; 103: 449\u201357.","DOI":"10.1046\/j.1365-2567.2001.01279.x"},{"key":"2022061622275233600_B32","doi-asserted-by":"crossref","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst\u20082000; 92: 205\u201316.","DOI":"10.1093\/jnci\/92.3.205"},{"key":"2022061622275233600_B33","doi-asserted-by":"crossref","unstructured":"Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol\u20082002; 23: 445\u20138.","DOI":"10.1016\/S1471-4906(02)02281-0"},{"key":"2022061622275233600_B34","doi-asserted-by":"crossref","unstructured":"Allan RS, Smith CM, Belz GT, et al. Epidermal viral immunity induced by CD8\u03b1+ dendritic cells but not by Langerhans cells. Science\u20082003; 301: 1925\u20138.","DOI":"10.1126\/science.1087576"},{"key":"2022061622275233600_B35","doi-asserted-by":"crossref","unstructured":"Zhao X, Deak E, Soderberg K, et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med\u20082003; 197: 153\u201362.","DOI":"10.1084\/jem.20021109"},{"key":"2022061622275233600_B36","doi-asserted-by":"crossref","unstructured":"Bennett CL, van Rijn E, Jung S, et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol\u20082005; 169: 569\u201376.","DOI":"10.1083\/jcb.200501071"},{"key":"2022061622275233600_B37","doi-asserted-by":"crossref","unstructured":"Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity\u20082005; 23: 611\u201320.","DOI":"10.1016\/j.immuni.2005.10.008"},{"key":"2022061622275233600_B38","doi-asserted-by":"crossref","unstructured":"Kissenpfennig A, Henri S, Dubois B, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity\u20082005; 22: 643\u201354.","DOI":"10.1016\/j.immuni.2005.04.004"},{"key":"2022061622275233600_B39","doi-asserted-by":"crossref","unstructured":"Guebre-Xabier M, Hammond SA, Epperson DE, Yu J, Ellingsworth L, Glenn GM. Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. J Virol\u20082003; 77: 5218\u201325.","DOI":"10.1128\/JVI.77.9.5218-5225.2003"},{"key":"2022061622275233600_B40","doi-asserted-by":"crossref","unstructured":"Frech SA, Kenney RT, Spyr CA, et al. Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine\u20082005; 23: 946\u201350.","DOI":"10.1016\/j.vaccine.2004.06.036"},{"key":"2022061622275233600_B41","doi-asserted-by":"crossref","unstructured":"Fan H, Lin Q, Morrissey GR, Khavari PA. Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol\u20081999; 17: 870\u20132.","DOI":"10.1038\/12856"},{"key":"2022061622275233600_B42","doi-asserted-by":"crossref","unstructured":"Morel PA, Falkner D, Plowey J, Larregina AT, Falo LD, Jr. DNA immunisation: altering the cellular localisation of expressed protein and the immunisation route allows manipulation of the immune response. Vaccine\u20082004; 22: 447\u201356.","DOI":"10.1016\/j.vaccine.2003.07.012"},{"key":"2022061622275233600_B43","doi-asserted-by":"crossref","unstructured":"Roy MJ, Wu MS, Barr LJ, et al. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine\u20082000; 19: 764\u201378.","DOI":"10.1016\/S0264-410X(00)00302-9"},{"key":"2022061622275233600_B44","doi-asserted-by":"crossref","unstructured":"Chen D, Payne LG. Targeting epidermal Langerhans cells by epidermal powder immunization. Cell Res\u20082002; 12: 97\u2013104.","DOI":"10.1038\/sj.cr.7290115"},{"key":"2022061622275233600_B45","doi-asserted-by":"crossref","unstructured":"Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med\u20082002; 8: 415\u20139.","DOI":"10.1038\/nm0402-415"},{"key":"2022061622275233600_B46","doi-asserted-by":"crossref","unstructured":"Chouaib S, Asselin-Paturel C, Mami-Chouaib F, Caignard A, Blay JY. The host tumor immune conflict: from immunosuppression to resistance and destruction. Immunology Today\u20081997; 18: 493\u20137.","DOI":"10.1016\/S0167-5699(97)01115-8"},{"key":"2022061622275233600_B47","doi-asserted-by":"crossref","unstructured":"Strand S, Galle PR. Immune evasion by tumours: involvement of the CD95 (APO-1\/Fas) system and its clinical implications. Mol Med Today\u20081998; 4: 63\u20138.","DOI":"10.1016\/S1357-4310(97)01191-X"},{"key":"2022061622275233600_B48","doi-asserted-by":"crossref","unstructured":"Ko EC, Wang X, Ferrone S. Immunotherapy of malignant diseases. Challenges and strategies. Int Arch Allergy Immunol\u20082003; 132: 294\u2013309.","DOI":"10.1159\/000074897"},{"key":"2022061622275233600_B49","doi-asserted-by":"crossref","unstructured":"Gilboa E. The risk of autoimmunity associated with tumor immunotherapy. Nat Immunol\u20082001; 2: 789\u201392.","DOI":"10.1038\/ni0901-789"},{"key":"2022061622275233600_B50","doi-asserted-by":"crossref","unstructured":"Lane C, Leitch J, Tan X, Hadjati J, Bramson JL, Wan Y. Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin. Cancer Res\u20082004; 64: 1509\u201314.","DOI":"10.1158\/0008-5472.CAN-03-3227"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/10136\/2554812\/10136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/10136\/2554812\/10136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T17:28:48Z","timestamp":1707326928000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/20\/10136\/526283\/Induction-of-Therapeutically-Relevant-Cytotoxic-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,15]]},"references-count":50,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2006,10,17]]},"published-print":{"date-parts":[[2006,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-1029","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,15]]}}}